NCT03521466

Brief Summary

The purpose of this randomized control trial is two- fold. The primary hypothesis of the study is that smoking cessation counseling delivered through trained medical students will lead to higher rates of abstinence amongst patients in the intervention group, as compared to a control group, when measured by self-reported and biochemical testing at 6 months after enrolment . The secondary hypothesis is that medical students engaging in a structured curriculum that includes counseling hospitalized smokers will show demonstrable increases in knowledge, confidence in their abilities, and use of smoking cessation techniques in regular practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

December 12, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2020

Completed
Last Updated

October 12, 2021

Status Verified

October 1, 2021

Enrollment Period

1.9 years

First QC Date

April 14, 2018

Last Update Submit

October 11, 2021

Conditions

Keywords

Smoking cessation counsellingMedical Student educationIndia

Outcome Measures

Primary Outcomes (1)

  • Biochemically verified 7 day quit rate measured 6 months after enrolment.

    At 6 months from enrolment, patients will be asked to report abstinence from smoking over the last 7 days (No more than 5 cigarettes in total since quit date); those who claim to have quit will be asked to provide biochemical confirmation by exhaled carbon monoxide breath testing (\<10 Parts Per Million will be considered a verified quit attempt).

    6 months from enrolment

Secondary Outcomes (9)

  • Biochemically verified 90 day quit rate, measured 6 months after enrolment

    6 months from enrolment

  • Number of patients achieving a 50% reduction in the number of cigarettes /bidis smoked in a week, measured at 2 and 6 months after enrolment

    2 and 6 months from enrolment

  • Correlation between verified quit rates at 6 months and FTND scores at enrolment

    6 months from enrolment

  • Number of patients who report having quit smoking in the last 7 days (irrespective of biochemical verification)

    2 and 6 months from enrolment

  • Agreement between self reported quit 7 day quit rate and biochemically verified 7 day quit rate, measured at 6 months from enrolment

    6 months from enrolment

  • +4 more secondary outcomes

Other Outcomes (3)

  • Number of eligible patients that receive inpatient counseling and atleast 3 follow up calls

    2 months from enrolment

  • Number of patients who use any form of cessation pharmacotherapy within the first 2 months

    2 months from enrolment

  • Number of patients enrolled in the study that are available for follow up at 6 months

    6 months from enrolment

Study Arms (2)

Intervention

EXPERIMENTAL

Smoking Cessation counseling by trained medical students with or without Nicotine Replacement Therapy

Behavioral: Smoking Cessation Counseling

Control

NO INTERVENTION

The control group will receive counseling and/or NRT at the discretion of the treating physician.

Interventions

Trained medical students will visit patients inpatient while hospitalized and provide smoking cessation counseling and recommend Nicotine Replacement Therapy. They will continue to follow these patients for 2 months after discharge and provide telephone-based counseling.

Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients age 18-70 years old, who are admitted to the medical, and if required surgical wards.
  • Patients must be current smokers (cigarettes and/or bidis) at the time of admission or report having smoked at all in the last 4 weeks prior to admission (to account for changes in behaviour during illness).
  • Patients living within 10 Km radius of the hospital.

You may not qualify if:

  • Unwilling to participate
  • Patients who use only non-smoked tobacco will be excluded.
  • Patients who are are daily alcohol users, daily cannabis or psychotropic drug users.
  • Patients who do not have a telephone/ unable to follow up
  • Patients unable to understand the local/common language
  • Patients with psychiatric conditions rendering them incapable of interacting with the providers
  • Medically unstable patients
  • Patients with expected hospital stay \<24 hours
  • Patients with life expectancy \< 12 months
  • Pregnant patients
  • Patients currently participating in a tobacco cessation program
  • Prior participation in this trial during another hospitalisation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PSG Institute of Medical Science and Research

Coimbatore, Tamil Nadu, 641004, India

Location

Related Publications (1)

  • Satish P, Khetan A, Shah D, Srinivasan S, Balakrishnan R, Padmanandan A, Hejjaji V, Hull L, Samuel R, Josephson R. Effectiveness of Medical Student Counseling for Hospitalized Patients Addicted to Tobacco (MS-CHAT): a Randomized Controlled Trial. J Gen Intern Med. 2023 Nov;38(14):3162-3170. doi: 10.1007/s11606-023-08243-y. Epub 2023 Jun 7.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Coordinators calling the patient to assess quit status are blinded to group assignment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director CVP Rehabilitation, Harrington Heart and Vascular Institute

Study Record Dates

First Submitted

April 14, 2018

First Posted

May 11, 2018

Study Start

December 12, 2018

Primary Completion

November 11, 2020

Study Completion

November 11, 2020

Last Updated

October 12, 2021

Record last verified: 2021-10

Locations